Don't Stop Dementia Drugs
Dementia sufferers 'failed by system'
DEMENTIA sufferers are being failed by the system, Care Services Minister Ivan Lewis admitted yesterday.
He was speaking at the launch of the first national strategy for dealing with the disease which affects about 600,000 people in England - a figure expected to double in the next 30 years.
Mr Lewis said: "We know that too many families feel the current NHS and social care systems are not meeting their needs. The current system is failing too many dementia sufferers and their carers."
During the launch in London, he said it was time to lift the disease "out of the shadows". Mr Lewis said that the disease, "which strikes fear into the hearts of all of us" is often wrongly diagnosed, for example, as depression.
The new strategy will look at three main ways to improve the diagnosis and treatment of dementia - increasing awareness of the disease, ensuring early diagnosis and providing higher-quality services.
Ideas to be considered include an information campaign with tips for detecting the first signs of dementia and staff training to improve diagnosis.
Ministers will announce a "transformation plan" next summer to improve dementia services across the country.
Also present at the announcement was Barbara Pointon, whose husband Malcolm, a pianist and composer, suffered from dementia.
Some of his final days were documented for the controversial ITV programme, Malcolm and Barbara: Love's Farewell, which will be screened tomorrow. Mrs Pointon said that the new strategy was "wonderful".
On Friday, the High Court will rule on the decision by the National Institute for Health and Clinical Excellence to restrict access to key drugs to those suffering from only moderate dementia.
Last year, The Northern Echo launched its Don't Stop Dementia Drugs campaign, which called on the NHS to provide Aricept, Exelon and Reminyl on the NHS to patients in the earlier stages of dementia.
The three drugs, which cost as little as £2.50 per person, per day, can help dementia sufferers carry out everyday tasks.
More than 3,000 readers backed our campaign by sending protests to the Department of Health.
But Mr Lewis insisted that the controversy over the three drugs would not obstruct the strategy's dealing with dementia. "By no means is the main or only issue about drugs and medication," he said.
Neil Hunt, chief executive of the Alzheimer's Society, said that yesterday was a "pivotal moment" for families affected by the disease.
"Dementia is the health and social care challenge of the century," he said. "This is an exciting opportunity to make sure the knowledge and expertise we now have about dementia care and treatment makes a difference to the lives of thousands of people throughout England."
New Alzheimer's drugs now being investigated may also prevent people going blind, research suggests.
Scientists at University College London have shown for the first time that proteins involved in Alzheimer's disease are also implicated in glaucoma.
9:30am Tuesday 7th August 2007
Print 
Email this
What are these links for?
If you liked this article and would like to share it with others on the web who might be searching for good content we've made it easy for you to do it.
At the bottom of all articles, you'll see links to six sites. These sites - commonly called 'social bookmark' or 'social news' sites - have large communities of web users who share and rate interesting, useful and fun things on the web.
Clicking the links will automatically add the address of the story you are reading to one of these sites, letting you share it with others. Each site will ask you to register to share stories. Registration is free and once a member, you can store, recommend and search for stories that interest you.
More on Digg
More on del.icio.us
More on Furl
More on reddit
More on NowPublic/
More on Yahoo!